>>Business Strategy

Teva/Ivax: Generics' Answer to Big Pharma

01 Sep 2005

Bigger generics companies aren't just the generic sector's problem. Giants such as the new Teva will present more formidable challenges to innovators, not just in patent wars but also with proprietary launches, and for a share of drug consumption in developing markets.

By Melanie Senior

Consolidation has been an ongoing feature of the generics industry, but it's stepping up a level. Barely had Novartis AG...